Long-Term Effects of Androgen Deprivation Therapy on Cognitive Function in Prostate Cancer Patients
DOI:
https://doi.org/10.63682/jns.v14i32S.7954Keywords:
Prostate cancer, androgen deprivation therapy, cognitive function, memory, executive functioning, quality of life, depressionAbstract
Background: Androgen deprivation therapy (ADT) remains foundational in managing advanced prostate cancer. Although quite successful at managing the progression of tumors, its impact on cognitive functioning over a prolonged period is concerning. This study sought to examine the association between ADT duration and cognitive performance among prostate cancer patients.
Methods: A cross-sectional study was carried out between January 2023 and December 2024 with 71 prostate cancer patients on ADT. Participants were categorized into two groups based on duration of therapy: less than 2 years, and 2 years or more. Cognitive domains were assessed using MMSE, MoCA, HVLT, Trail Making B Test and Clock Drawing test. Other Depressive symptoms, fatigue, and quality of life were also measured. ‘Data analysis was conducted with SPSS v25 with significance set at p < 0.05’.
Results: Patients on long-term ADT exhibited significantly lower scores in global cognition, memory, executive functioning, and visuospatial tasks compared to those on short-term therapy. Mean MMSE and MoCA scores were lower in the long-term group (26.4 vs. 27.9 and 22.1 vs. 24.2, respectively). Depression scores and fatigue levels were higher, while quality of life was significantly reduced in patients receiving ADT for two years or more.
Conclusion: Prolonged ADT use in prostate cancer patients is associated with a decline in cognitive performance and psychosocial well-being. These findings support the need for cognitive monitoring and multidisciplinary support during long-term hormone therapy.
Downloads
Metrics
References
Holtfrerich, S.K.C., et al., The impact of long‐term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients. Psycho‐Oncology, 2020. 29(8): p. 1338-1346.
Andela, C.D., et al., Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review. International Journal of Urology, 2021. 28(8): p. 786-798.
Sánchez-Martínez, V., et al., Analysis of brain functions in men with prostate cancer under androgen deprivation therapy: a one-year longitudinal study. Life, 2021. 11(3): p. 227.
Shim, M., et al., Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link? Prostate international, 2022. 10(1): p. 68-74.
Cinar, O., et al., Effects of androgen deprivation therapy on cognitive functions in patients with metastatic prostate cancer: A multicentric, prospective study of the Society of Urological Surgery Andrology group. International journal of clinical practice, 2021. 75(6): p. e14095.
Lee, H.H., et al., How does androgen deprivation therapy affect mental health including cognitive dysfunction in patients with prostate cancer? The World Journal of Men's Health, 2020. 39(4): p. 598.
Cherrier, M.M. and C.S. Higano. Impact of androgen deprivation therapy on mood, cognition, and risk for AD. in Urologic Oncology: Seminars and Original Investigations. 2020. Elsevier.
Reiss, A.B., et al., Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood. Medicina, 2023. 60(1): p. 77.
Marandino, L., et al., Evaluation of cognitive function in trials testing new-generation hormonal therapy in patients with prostate cancer: a systematic review. Cancers, 2020. 12(9): p. 2568.
Ryan, C., J.S. Wefel, and A.K. Morgans, A review of prostate cancer treatment impact on the CNS and cognitive function. Prostate Cancer and Prostatic Diseases, 2020. 23(2): p. 207-219.
Yamamoto, Y., et al., Impact of androgen deprivation therapy on cognitive function in men with prostate cancer. BJUI compass, 2023. 5(3): p. 356.
Quiñones, H.J.A., et al., Prostate cancer, use of androgen deprivation therapy, and cognitive impairment: a population-based study. Alzheimer Disease & Associated Disorders, 2020. 34(2): p. 118-121.
Ceylan, Y., et al., The depressive effects of androgen deprivation therapy in locally advanced or metastatic prostate cancer: a comparative study. The Aging Male, 2020. 23(5): p. 733-739.
Tulk, J., et al., Androgen deprivation therapy and radiation for prostate cancer—Cognitive impairment, sleep, symptom burden: A prospective study. BMJ Supportive & Palliative Care, 2021. 13(e2): p. e454-e463.
Hong, J.-H., et al., Different androgen deprivation therapies might have a differential impact on cognition-An analysis from a population-based study using time-dependent exposure model. Cancer epidemiology, 2020. 64: p. 101657.
Morgans, A.K., et al., Risk of cognitive effects in comorbid patients with prostate cancer treated with androgen receptor inhibitors. Clinical Genitourinary Cancer, 2021. 19(5): p. 467. e1-467. e11.
Alonso-Quiñones, H., et al., Androgen deprivation therapy use and risk of mild cognitive impairment in prostate cancer patients. Alzheimer Disease & Associated Disorders, 2021. 35(1): p. 44-47.
Hinojosa-Gonzalez, D.E., et al., Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 2024. 27(3): p. 507-519.
Ihrig, A., et al., Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer. International Urology and Nephrology, 2023. 55(11): p. 2733-2739.
Beer, T.M., et al., Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer. BJUI compass, 2022. 3(6): p. 424-433.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
